Applications Published 25 April 2001

Published: 19-Jan-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Methods and transdermal compsns for pain relief
    Pharmaceutical Applications Associates 1093348*

  • Method of reducing or preventing malodour
    Unilever 1093354*

  • Method of reducing or preventing malodour
    Quest International 1093355*

  • Plaster which contains steroids, and a method for the production and use thereof
    LTS Lohamnn 1093361*

  • Treatment of anti-estrogen resistant breast cancer using RXR modulators
    Ligand Pharmaceuticals 1093362*

  • Methods and compsns for treatment of disorders associated with chlamydial and similar bacterial infection
    Baumgart, Karl William; Borody, Thomas Julius 1093363*

  • A method for stimulation of defensin prouction by exposure to isoleucin
    Magainin Pharmaceuticals 1093364*

  • Compsn comprising GABA analogs abd a decongestant to relieve sinus headache pain
    Warner-Lambert 1093365*

  • Pharmaceutical compsn containing GABA analogs and an antiviral agent to treat shingles
    Warner-Lambert 1093366*

  • Protease inhibitors
    SmithKline Beecham 1093367*

  • Indole and tetrahydroisoquinoline containing a-keto oxadiazoles as serine protease inhibitors
    Cortech 1093368*

  • Agents with antidepressive effect
    Beohringer Ingelheim Pharma 1093369*

  • Pharmaceutical compsn for the treatment of diabetes
    Takeda Chemical Industries 1093370*

  • Use of FK506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain
    Fujisawa Pharmaceuticals 1093371*

  • Cyclic amino acid compounds, pharmaceutical compsns comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds
    Elan Pharmaceuticals 1093372*

  • Oligonucleotide inhibitors of BCL-XL
    The Trustees of Columbia University in the City of New York 1093373*

  • Hypo-osmotic saline solutions, method of preparing the same, and medicines based on said solutions
    Laboratoires Goemar 1093374*

  • A fibrin sealant from clotting factors in fish blood
    Sea Run Holdings 1093375*

  • Compsn and method for treatment of inflammation and pain in mammals
    Metagenics 1093376*

  • Inclusion of apoptopic regulators in solutions for cell strorage at low temperature
    Biolife Solutions 1093377*

  • Compsns and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
    The Trustees of the University of Pennsylvania 1093378*

  • Use of inhibitors of protein kinase C epsilon to treat pain
    Messing, Robert 1093379*

  • Component B as angiogenic agent in combination with human growth factors
    Applied Research Systems 1093380*

  • Antigenic peptides derived from telomerase
    Norsk Hydro 1093381*

  • Use of an amphipathic compound for providsing an adjuvant to a subunit vaccine
    Aventis Pasteur 1093382*

  • Dsrug delivery system comprising a homeobox peptide
    Cyclacel 1093383*

  • Implant with a composite coating
    Hayes Medical 1093384*

  • Desformoterol and process for its preparation
    Sepracor 1093450*

  • Solid compsns suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl L-carnitines
    Sigma-Tau Industries Farmaceutiche Reunite 1093451*

  • Method for the preparation of organic carbamates
    Huntsman International 1093452*

  • Naaladase inhibitors useful as pharmaceutical compounds and compsns
    Guilford Pharmaceuticals 1093453*

  • Chiral compounds and their use as doping agents in liquid crystals
    Rolic 1093454*

  • Bis-indole derivatives and their use as antiinflammatory agents
    Harbor Branch Oceanographic Institute 1093455*

  • Naphtho- and dihydrobenzo-thiophene derivatives and their use as cytotoxic antitumour agents
    University of North Carolina at Chapel Hill 1093456*

  • Cytokine receptor common gamma chain like
    Human Genome Sciences 1093457*

  • Process for the preparation of resin-bound cyclic peptides
    Aventis Pharmaceuticals 109345*

  • Chemically modified proteins with a carbohydrate moiety
    Genecor International. 1093459*

  • Dolastin 15 derivatives
    BASF; BASF Bioresearch 1093460*

  • Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses
    Centre National de la Recherche Scientifique 1093461*

  • Compound capable of inhibiting the binding of a protein t mast cells, use of the compound for the preparation of a drug, a pharmaceutiucal compsn, a method of diagnosing a disease, and a method of selection
    Universiteit Utrecht 1093462*

  • A method of preparing a compound with growth hormone releasing properties
    Novo Nordisk 1093463*

  • Compounds, compsns and methods for endocytic presentation of immunosuppressive factors
    The University of Tennessee Research Corp 1093464*

  • Method of producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means
    Alexis Biotech 1093465*

  • Method for preparing hydroxyalkyl starch
    Grain Processing Corp 1093466*

  • Process for selective oxidation of primary alcohols
    Nederlandse Organisatie voor Toegepast Natuurwtenschappelijk 1093467*

  • Polymers for delivering nitric oxide in vivo
    Duke University Medical Centre 1093468*

  • Linear cyclodextrin copolymers
    California Institute of Technology 1093469*

  • Neisseria meningitidis antigens and compsns
    Chiron 1093517*

  • Stabilised variants of steptomyces substilisin inhibitor
    Procter & Gamble 1093518*

  • Aphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
    The University of Southern California 1093519*

  • HMP-P kinase and TMP-PPase from Arabidopsis thaliana and their use in herbicide screening
    Syngenta Participations 1093520*

  • Human transferases
    Incyte Pharmaceuticals 1093521*

  • Proteases fused with variants of streptomyces subtilisin inhibitor
    Procter & Gamble 1093522*

  • Recombinant herpes viruses for preparing recombinant adeno-associated viruses
    Heilbronn, Regine 1093524*

  • Improved microbial strains producing sphingoid bases
    Cosmoferm 1093525*
  • You may also like